Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Jan/15/2021 28 3
Convalescent plasma Emergency use authorization Experimental Antiviral Jan/15/2021 27 5
IVIg Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/24/2020 4 2
Breast milk Potential treatment - pre-clinical evidence Natural product Antiviral Dec/01/2020 2 0
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral Nov/25/2020 19 5
Taxifolin Potential treatment - theoretical effect Natural product Antiviral Nov/25/2020 2 0
GD1-69 Potential treatment - pre-clinical evidence Experimental Antiviral Nov/25/2020 1 0
Luminol sodium salt Potential treatment - pre-clinical evidence Experimental Antiviral Nov/20/2020 1 0
Prednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Oct/14/2020 4 0